Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Current state and future perspectives of the Latin American Society for Immunode...
Journal Information
Vol. 43. Issue 5.
Pages 493-497 (September - October 2015)
Download PDF
More article options
Vol. 43. Issue 5.
Pages 493-497 (September - October 2015)
Series: Primary Immunodeficiencies in Latin America (III)
DOI: 10.1016/j.aller.2014.05.007
Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID)
A. Condino-Netoa, R.U. Sorensenb,c, A.C. Gómez Racciod, A. Kinge, F.J. Espinosa-Rosalesf, J.L. Francog,
Corresponding author
a Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
b Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA
c School of Medicine, University of La Frontera, Temuco, Chile
d Immunology Group, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina
e Hospital Luis Calvo Mackenna, Santiago, Chile
f Unidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, Mexico City, Mexico
g Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia, Medellín, Colombia
Article information
Full Text
Download PDF
Figures (1)
Tables (1)
Table 1. List of the participating countries and number of centres in the LASID registry.

Primary immunodeficiencies (PID) are genetic diseases that affect the immune system and for the last 20 years, the Latin American Society for Immunodeficiencies (LASID) has been promoting initiatives in awareness, research, diagnosis, and treatment for the affected patients in Latin America. These initiatives have resulted in the development of programmes such as the LASID Registry (with 4900 patients registered as of January 2014), fellowships in basic and clinical research, PID summer schools, biannual meetings, and scientific reports, amongst others. These achievements highlight the critical role that LASID plays as a scientific organisation in promoting science, research and education in this field in Latin America. However, challenges remain in some of these areas and the Society must envision additional strategies to tackle them for the benefit of the patients. In June 2013, a group of experts in the field met to discuss the contributions of LASID to the initiatives of PID in Latin America, and this article summarises the current state and future perspectives of this society and its role in the advance of PIDs in Latin America.

Primary immunodeficiency
Latin America


These are the options to access the full texts of the publication Allergologia et Immunopathologia

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Allergologia et Immunopathologia

Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.